Date: 2017-02-07
Type of information: Resignation
Compound:
Company: Pieris (Germany)
Therapeutic area: Autoimmune diseases - Cancer - Oncology
Type agreement: resignation
Action mechanism:
Disease:
Details:
- • On February 17, 2017, Pieris Pharmaceuticals announced that Darlene Deptula-Hicks has submitted her resignation, effective immediately, to pursue other interests. While the company conducts an executive search for a permanent successor, Lance Thibault of Danforth Advisors, is assuming the role of Acting Chief Financial Officer.
- Ms. Darlene Deptula-Hicks joined Pieris Pharmaceuticals as Senior Vice President and Chief Financial Officer in September 2015. Prior to this, Ms. Deptula-Hicks was engaged as a financial consultant to Pieris and was appointed as Acting Chief Financial Officer and Treasurer in December 2014.
Financial terms:
Latest news:
Is general: Yes
